If your genetic testing shows you have high cortisol sensitivity or reduced stress resilience, ashwagandha may meaningfully enhance your semaglutide results by lowering the inflammatory and hormonal barriers to weight loss
GLP-1 patents and Africa: The COVID-19 lessons we still have not learned Weight loss drugs promise a diabetes breakthrough in Africa, but patent barriers stall access
In a pediatric clinical trial, there was one episode of serious suicidal ideation in a QSYMIA-treated patient requiring hospitalization and pharmacologic treatment [see Warnings and Precautions (5.2)] more patients treated with QSYMIA versus placebo reported adverse reactions related to mood (e.g., depression, anxiety) and sleep disorders (e.g., insomnia) [see Warnings and Precautions (5.4)]
Its impossible to know if this is due to reduced absorption or just the typical pill failure rate of 9% annually with typical use, but the theoretical risk is concerning enough that many doctors recommend alternative contraception
Nausea was the most common adverse event, significantly higher in the GLP-1RA group compared to placebo